PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Allarity Therapeutics, Inc. (ALLR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS0167441049
CUSIP016744104
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$2.04M
EPS-$205.20
PE Ratio0.00
PEG Ratio1.81
Revenue (TTM)-$7.13M
Gross Profit (TTM)-$36.35M
EBITDA (TTM)-$17.09M
Year Range$0.71 - $315.92
Target Price$5.00
Short %9.27%
Short Ratio0.15

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Allarity Therapeutics, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Allarity Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%December2024FebruaryMarchAprilMay
-100.00%
13.93%
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Allarity Therapeutics, Inc. had a return of -93.90% year-to-date (YTD) and -99.76% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-93.90%11.05%
1 month-59.95%4.86%
6 months-93.14%17.50%
1 year-99.76%27.37%
5 years (annualized)N/A13.14%
10 years (annualized)N/A10.90%

Monthly Returns

The table below presents the monthly returns of ALLR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-21.14%-11.04%-22.12%-78.91%-93.90%
2023-14.91%-26.00%-74.05%-73.81%-40.11%-37.38%-61.52%-27.17%-59.62%-25.44%-0.69%-0.37%-99.87%
2022-21.25%-48.23%-51.77%-24.02%82.58%-53.36%-9.09%-2.50%-5.98%-49.08%-19.84%-34.57%-97.17%
2021-1.20%-1.20%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALLR is 5, indicating that it is in the bottom 5% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ALLR is 55
ALLR (Allarity Therapeutics, Inc.)
The Sharpe Ratio Rank of ALLR is 66Sharpe Ratio Rank
The Sortino Ratio Rank of ALLR is 00Sortino Ratio Rank
The Omega Ratio Rank of ALLR is 00Omega Ratio Rank
The Calmar Ratio Rank of ALLR is 00Calmar Ratio Rank
The Martin Ratio Rank of ALLR is 1717Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Allarity Therapeutics, Inc. (ALLR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ALLR
Sharpe ratio
The chart of Sharpe ratio for ALLR, currently valued at -0.88, compared to the broader market-2.00-1.000.001.002.003.004.00-0.88
Sortino ratio
The chart of Sortino ratio for ALLR, currently valued at -5.15, compared to the broader market-4.00-2.000.002.004.006.00-5.15
Omega ratio
The chart of Omega ratio for ALLR, currently valued at 0.39, compared to the broader market0.501.001.502.000.39
Calmar ratio
The chart of Calmar ratio for ALLR, currently valued at -1.00, compared to the broader market0.002.004.006.00-1.00
Martin ratio
The chart of Martin ratio for ALLR, currently valued at -1.12, compared to the broader market-10.000.0010.0020.0030.00-1.12
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.49, compared to the broader market-2.00-1.000.001.002.003.004.002.49
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.006.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.501.001.502.001.43
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.03, compared to the broader market0.002.004.006.002.03
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.57, compared to the broader market-10.000.0010.0020.0030.009.57

Sharpe Ratio

The current Allarity Therapeutics, Inc. Sharpe ratio is -0.88. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Allarity Therapeutics, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.88
2.49
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Allarity Therapeutics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-100.00%
-0.21%
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Allarity Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Allarity Therapeutics, Inc. was 100.00%, occurring on May 16, 2024. The portfolio has not yet recovered.

The current Allarity Therapeutics, Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Dec 23, 2021602May 16, 2024

Volatility

Volatility Chart

The current Allarity Therapeutics, Inc. volatility is 37.69%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%December2024FebruaryMarchAprilMay
37.69%
3.40%
ALLR (Allarity Therapeutics, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Allarity Therapeutics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items